Results 61 to 70 of about 830,210 (192)

Design, Synthesis and Molecular Docking Studies of Some Novel Hydrazone Derivatives Based on Trimetazidine as Selective and Potent AChE Inhibitors

open access: yesDrug Development Research, Volume 87, Issue 7, November 2026.
ABSTRACT Alzheimer's disease (AD) is a progressive neurodegenerative disease, and cholinergic dysfunction is considered one of the fundamental pathological factors of this disease. Guided by the clinically used acetylcholinesterase (AChE) inhibitor donepezil, we explored trimetazidine dihydrochloride as an accessible starting scaffold to generate ...
Muhammed Oğuzhan Doğan   +6 more
wiley   +1 more source

The Dementia Orchestra

open access: yes
Journal of the American Geriatrics Society, EarlyView.
David B. Reuben
wiley   +1 more source

Hesperidin as a Multi‐Target Phytochemical: Therapeutic Applications, Medicinal Chemistry Insights, and Advances in Synthetic Analogs

open access: yesFood Frontiers, Volume 7, Issue 6, November 2026.
This review offers a thorough examination of the therapeutic uses of hesperidin, emphasizes significant findings from structure‐activity relationship research, and addresses recent advancements in the synthesis and biological assessment of hesperidin analogs.
Mohammadsaeed Kordi   +5 more
wiley   +1 more source

Effects of Mannitol on Rumen and Fecal Microbiome, Immune Function, and Antioxidant Capacity of Sunit Sheep

open access: yesFood Science &Nutrition, Volume 14, Issue 11, November 2026.
This graphical abstract illustrates the effects of uncoated and coated mannitol supplementation on ruminal and fecal microbiomes, serum immune indices, antioxidant status, and metabolism in Sunit sheep. Neither uncoated nor coated mannitol altered growth performance.
Min Li   +6 more
wiley   +1 more source

Vocal Fold Atrophy in Patients With Alzheimer's Disease and Related Dementias

open access: yesThe Laryngoscope, Volume 136, Issue 11, Page 4896-4902, November 2026.
This is the first study to quantify vocal fold atrophy in patients with Alzheimer's disease and related dementias (AD/ADRD) using endoscopic imaging. Compared with age‐matched controls, AD/ADRD patients showed significantly greater vocal fold bowing and reduced mucosal wave amplitude, while normalized glottal gap area did not differ.
Byron Kim   +5 more
wiley   +1 more source

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He   +4 more
wiley   +1 more source

Alzheimer's Disease: Mechanisms and Therapeutic Advances

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Alzheimer's disease involves Aβ/tau aggregation, neuroinflammation, BBB leakage, gut–brain dysfunction, and mitochondrial damage, causing neuronal loss. Nanodelivery enables combined small‐molecule and targeted therapies. Disease‐modifying biologics/chemicals, including anti‐Aβ antibodies, raise safety and access concerns. Exercise, cognitive training,
Gaoshuang Fu   +4 more
wiley   +1 more source

Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy

open access: yesMovement Disorders Clinical Practice, Volume 13, Issue 11, Page 3019-3025, November 2026.
Abstract Background Progressive supranuclear palsy (PSP) is a neurodegenerative disorder characterized by motor, oculomotor and cognitive impairments. Yet disentangling cognitive deficits from motor and oculomotor dysfunction remains a diagnostic and methodological challenge.
Indira Garcia‐Cordero   +12 more
wiley   +1 more source

Natural cholinesterase inhibitors from marine organisms

open access: yes, 2019
Covering: Published between 1974 up to 2018Inhibition of cholinesterases is a common approach for the management of several disease states. Most notably, cholinesterase inhibitors are used to alleviate the symptoms of neurological disorders like dementia
Svenson, Johan   +8 more
core   +1 more source

Home - About - Disclaimer - Privacy